查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405788

中心实验室市场规模、份额、趋势分析报告：按服务、按最终用途、按地区、细分市场预测，2024-2030 年

Central Lab Market Size, Share & Trends Analysis Report By Service (Genetic Services, Biomarker Services), By End-use (Pharmaceutical Companies, Biotechnology Companies), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

中心实验室市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球中心实验室市场规模将达到50.5亿美元，2024年至2030年复合年增长率为6.44%。

由于研发投资增加以及申办者和临床实验更加重视降低研究成本，预计预测期内复合年增长率为 6.50%。中心业务营运外包是推动市场成长的关键因素。

中心实验室业务外包是临床试验产业的成长趋势，预计将为中心实验室创造利润丰厚的商机。临床实验和申办者外包了大约 80% 的中心实验室业务，更喜欢提供端到端整合服务的实验室。

近年来，由于大流行期间对製药业的关注日益增加，研发投资激增。随着我们进入大流行的第三年，对科学的投资加强了研发管线，多项临床试验已经开始。疫情期间，介入研究活动稳定扩大。製药业开发了新的试验实施方法来管理大流行期间正在进行的临床试验。

这场大流行也创造了新的成长机会，包括人们更加关注开发 mRNA 疫苗和探索几种 COVID-19治疗方法。然而，样本处理、供应链和物流对于送到临床实验室的样本起着至关重要的作用。这些样品高度敏感，需要快速物流和温度控制，从而保持样品稳定性以获得最准确的结果。

中小型中央侦测机构的崛起正在加剧全球竞争。中小型中心实验室的存在在亚太等发展中地区非常突出。此外，在新兴经济体进行临床试验的成本较低，有利于选择位于这些地区的中心实验室。这是由于较低的物流成本和靠近临床试验施行地点。

中央实验室市场报告亮点

  • 由于基因分析在临床研究中的重要性日益增加，预计基因服务产业将以最快的速度成长。
  • 策略性收购是影响市场动态变化的因素之一。例如，大中型企业为了加强全球扩张或进入新业务领域而进行收购。
  • 由于干预研究和研究投资的增加，製药公司在最终用途方面占据了最大的市场占有率。
  • 由于糖尿病和癌症等疾病领域的个体化医疗保健相关临床试验中基因检测的需求不断增加，2023年的全球市场将由北美主导。
  • 该市场的主要企业包括 ACM Global Laboratories、Labconnect、Cerba Research、Eurofins Scientific、Medicover Integrated Clinical Services 和 Versiti。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场驱动因素
    • 加大临床试验研发投入
    • 新药需求不断成长
    • 中央检验业务外包
    • 降低药物研究成本
  • 市场抑制因素分析
    • 物流和样品处理
  • 营商环境分析
    • SWOT 分析；按因素（政治/法律、经济/技术）
    • 波特五力分析
    • COVID-19感染疾病的影响分析

第四章服务业务分析

  • 中心实验室市场：服务波动分析
  • 遗传服务
  • 生物标誌服务
  • 微生物学服务
  • 解剖病理学/组织学
  • 检体管理及储存
  • 特种化学品服务
  • 其他的

第五章 最终用途业务分析

  • 中心实验室市场：最终用途变化分析
  • 製药公司
  • 生技公司
  • 学术研究所

第六章 区域业务分析

  • 2023年及2030年按地区市场占有率
  • 北美洲
    • 北美中心实验室市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲中心实验室市场，2018-2030
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太中心实验室市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲中心实验室市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • MEA 中心实验室市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章竞争形势

  • 参与企业概况
  • 财务绩效
  • 参与企业
    • 市场领导者
    • 2023 年中心实验室市场占有率分析
    • 公司简介
    • 策略规划
Product Code: GVR-4-68039-962-2

Central Lab Market Growth & Trends:

The global central lab market size is expected to reach USD 5.05 billion by 2030, expanding at a CAGR of 6.44% from 2024 to 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 6.50% during the forecast period, driven by the increasing investment in R&D and increased focus of sponsors & investigators on reducing research costs. The outsourcing of central lab work is a significant factor driving the market growth.

Outsourcing central lab work is a rising trend in the clinical trial industry, which is expected to create lucrative business opportunities for central labs. The investigators and sponsors outsource ~80% of the central lab work and prefer the labs that provide end-to-end integrated services.

Investment in R&D has witnessed a surge in past years, which can be attributed to the enhanced focus on the pharmaceutical industry during the pandemic. As we enter the third year of the pandemic, investment in science has enhanced the pipeline and several clinical trials have been initiated. Over the pandemic, activity in interventional studies grew steadily. The pharmaceutical industry developed a new way of conducting trials for the management of ongoing clinical trials during the pandemic.

The pandemic has also created new growth opportunities, with an increasing focus on mRNA vaccine development and investigations for several COVID-19 treatment options. However, sample handling, supply chain, and logistics play a significant role in the sample sent to clinical labs. These samples are highly sensitive and require fast logistics with temperature control, thereby maintaining sample stability to get the most accurate results.

The rise of small- and medium-scale central laboratories is intensifying the competition globally. The presence of small- and medium-scale central labs is highly prominent in developing regions such as the Asia Pacific. These laboratories are becoming critical in the management of clinical trials globally owing to the availability of central laboratory services at 20%-35% lower prices, when compared to Europe and the U.S. Furthermore, the lower cost of conducting clinical trials in the developing economies facilitates the selection of central laboratories present in these regions, which can be attributed to lower logistic costs and presence near the trial location.

Central Lab Market Report Highlights:

  • The genetic services segment is anticipated to grow at the fastest growth rate, owing to the increasing significance of genetic analysis in clinical studies
  • Strategic acquisitions are one of the factors influencing the changing dynamics of the market. For instance, players are acquired by medium and large-scale enterprises for enhancing their global reach and entering new business segments
  • Pharmaceutical companies held the largest market share by end-use, attributable to an increasing number of interventional studies and investment into research
  • North America dominated the global market in 2023, the increasing need for genetic testing in clinical trials related to personalized healthcare in disease areas, such as diabetes & cancers
  • Key players in the market include ACM Global Laboratories, Labconnect, Cerba Research, Eurofins Scientific, Medicover Integrated Clinical Services, and Versiti

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers
    • 3.4.1. Rising R&D investment in clinical trial
    • 3.4.2. Escalating demand for novel drugs
    • 3.4.3. Outsourcing of central lab work
    • 3.4.4. Reducing the cost of drug research
  • 3.5. Market Restraint Analysis
    • 3.5.1. Logistics and sample handling
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Service Business Analysis

  • 4.1. Central Lab Market: Service Movement Analysis
  • 4.2. Genetic Services
    • 4.2.1. Genetic Services Central Lab Market, 2018 - 2030 (USD Million)
  • 4.3. Biomarker Services
    • 4.3.1. Biomarker Services Central Lab Market, 2018 - 2030 (USD Million)
  • 4.4. Microbiology Services
    • 4.4.1. Microbiology Services Central Lab Market, 2018 - 2030 (USD Million)
  • 4.5. Anatomic Pathology/Histology
    • 4.5.1. Anatomic Pathology/Histology Central Lab Market, 2018 - 2030 (USD Million)
  • 4.6. Specimen Management and Storage
    • 4.6.1. Specimen Management and Storage Central Lab Market, 2018 - 2030 (USD Million)
  • 4.7. Special Chemistry Services
    • 4.7.1. Special Chemistry Services Central Lab Market, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Central Lab Market, 2018 - 2030 (USD Million)

Chapter 5. End Use Business Analysis

  • 5.1. Central Lab Market: End-Use Movement Analysis
  • 5.2. Pharmaceutical Companies
    • 5.2.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 5.3. Biotechnology Companies
    • 5.3.1. Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 5.4. Academic and Research Institutes
    • 5.4.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Central Lab Market Share By Region, 2023 & 2030
  • 6.2. North America
    • 6.2.1. North America Central lab market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Target Disease Prevalence
      • 6.2.2.3. Competitive Scenario
      • 6.2.2.4. Regulatory Framework
      • 6.2.2.5. Reimbursement Scenario
      • 6.2.2.6. U.S. Central lab market, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Target Disease Prevalence
      • 6.2.3.3. Competitive Scenario
      • 6.2.3.4. Regulatory Framework
      • 6.2.3.5. Reimbursement Scenario
      • 6.2.3.6. Canada Central lab market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Central lab market, 2018 - 2030 (USD Million)
    • 6.3.2. Germany
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Target Disease Prevalence
      • 6.3.2.3. Competitive Scenario
      • 6.3.2.4. Regulatory Framework
      • 6.3.2.5. Reimbursement Scenario
      • 6.3.2.6. Germany Central lab market, 2018 - 2030 (USD Million)
    • 6.3.3. UK
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Target Disease Prevalence
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. Regulatory Framework
      • 6.3.3.5. Reimbursement Scenario
      • 6.3.3.6. UK Central lab market, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Target Disease Prevalence
      • 6.3.4.3. Competitive Scenario
      • 6.3.4.4. Regulatory Framework
      • 6.3.4.5. Reimbursement Scenario
      • 6.3.4.6. France Central lab market, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Target Disease Prevalence
      • 6.3.5.3. Competitive Scenario
      • 6.3.5.4. Regulatory Framework
      • 6.3.5.5. Reimbursement Scenario
      • 6.3.5.6. Italy Central lab market, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Target Disease Prevalence
      • 6.3.6.3. Competitive Scenario
      • 6.3.6.4. Regulatory Framework
      • 6.3.6.5. Reimbursement Scenario
      • 6.3.6.6. Spain Central lab market, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Target Disease Prevalence
      • 6.3.7.3. Competitive Scenario
      • 6.3.7.4. Regulatory Framework
      • 6.3.7.5. Reimbursement Scenario
      • 6.3.7.6. Denmark Central lab market, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Target Disease Prevalence
      • 6.3.8.3. Competitive Scenario
      • 6.3.8.4. Regulatory Framework
      • 6.3.8.5. Reimbursement Scenario
      • 6.3.8.6. Sweden Central lab market, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Target Disease Prevalence
      • 6.3.9.3. Competitive Scenario
      • 6.3.9.4. Regulatory Framework
      • 6.3.9.5. Reimbursement Scenario
      • 6.3.9.6. Norway Central lab market, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Central lab market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Regulatory Framework
      • 6.4.2.5. Reimbursement Scenario
      • 6.4.2.6. Japan Central lab market, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Regulatory Framework
      • 6.4.3.5. Reimbursement Scenario
      • 6.4.3.6. China Central lab market, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. Regulatory Framework
      • 6.4.4.5. Reimbursement Scenario
      • 6.4.4.6. India Central lab market, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Target Disease Prevalence
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. Regulatory Framework
      • 6.4.5.5. Reimbursement Scenario
      • 6.4.5.6. South Korea Central lab market, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Target Disease Prevalence
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Regulatory Framework
      • 6.4.6.5. Reimbursement Scenario
      • 6.4.6.6. Australia Central lab market, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Target Disease Prevalence
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. Regulatory Framework
      • 6.4.7.5. Reimbursement Scenario
      • 6.4.7.6. Thailand Central lab market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Central lab market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Regulatory Framework
      • 6.5.2.5. Reimbursement Scenario
      • 6.5.2.6. Brazil Central lab market, 2018 - 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Regulatory Framework
      • 6.5.3.5. Reimbursement Scenario
      • 6.5.3.6. Mexico Central lab market, 2018 - 2030 (USD Million)
    • 6.5.4. Argentina
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Regulatory Framework
      • 6.5.4.5. Reimbursement Scenario
      • 6.5.4.6. Argentina Central lab market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Central lab market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. Regulatory Framework
      • 6.6.2.5. Reimbursement Scenario
      • 6.6.2.6. South Africa Central lab market, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. Regulatory Framework
      • 6.6.3.5. Reimbursement Scenario
      • 6.6.3.6. Saudi Arabia Central lab market, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. Regulatory Framework
      • 6.6.4.5. Reimbursement Scenario
      • 6.6.4.6. UAE Central lab market, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Regulatory Framework
      • 6.6.5.5. Reimbursement Scenario
      • 6.6.5.6. Kuwait Central lab market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant's overview
  • 7.2. Financial performance
  • 7.3. Participant categorization
    • 7.3.1. Market Leaders
    • 7.3.2. Central Lab Market Share Analysis, 2023
    • 7.3.3. Company Profiles
      • 7.3.3.1. ACM Global Laboratories
      • 7.3.3.1.1. Company Overview
      • 7.3.3.1.2. Financial Performance
      • 7.3.3.1.3. Product Benchmarking
      • 7.3.3.1.4. Strategic Initiatives
      • 7.3.3.2. LabConnect
      • 7.3.3.2.1. Company Overview
      • 7.3.3.2.2. Financial Performance
      • 7.3.3.2.3. Product Benchmarking
      • 7.3.3.2.4. Strategic Initiatives
      • 7.3.3.3. Cerba Research
      • 7.3.3.3.1. Company Overview
      • 7.3.3.3.2. Financial Performance
      • 7.3.3.3.3. Product Benchmarking
      • 7.3.3.3.4. Strategic Initiatives
      • 7.3.3.4. Eurofins Scientific
      • 7.3.3.4.1. Company Overview
      • 7.3.3.4.2. Financial Performance
      • 7.3.3.4.3. Product Benchmarking
      • 7.3.3.4.4. Strategic Initiatives
      • 7.3.3.5. Versiti (Cenetron)
      • 7.3.3.5.1. Company Overview
      • 7.3.3.5.2. Financial Performance
      • 7.3.3.5.3. Product Benchmarking
      • 7.3.3.5.4. Strategic Initiatives
      • 7.3.3.6. Medicover Integrated Clinical Services (MICS) (Synevo Central Labs)
      • 7.3.3.6.1. Company Overview
      • 7.3.3.6.2. Financial Performance
      • 7.3.3.6.3. Product Benchmarking
      • 7.3.3.6.4. Strategic Initiatives
      • 7.3.3.7. A.P. Møller Holding A/S (Unilabs)
      • 7.3.3.7.1. Company Overview
      • 7.3.3.7.2. Financial Performance
      • 7.3.3.7.3. Product Benchmarking
      • 7.3.3.7.4. Strategic Initiatives
      • 7.3.3.8. Ampersand Capital Partners (Pacific Biomarkers)
      • 7.3.3.8.1. Company Overview
      • 7.3.3.8.2. Financial Performance
      • 7.3.3.8.3. Product Benchmarking
      • 7.3.3.8.4. Strategic Initiatives
      • 7.3.3.9. Lambda Therapeutic Research Ltd
      • 7.3.3.9.1. Company Overview
      • 7.3.3.9.2. Financial Performance
      • 7.3.3.9.3. Product Benchmarking
      • 7.3.3.9.4. Strategic Initiatives
      • 7.3.3.10. CIRION BioPharma Research Inc.
      • 7.3.3.10.1. Company Overview
      • 7.3.3.10.2. Financial Performance
      • 7.3.3.10.3. Product Benchmarking
      • 7.3.3.10.4. Strategic Initiatives
    • 7.3.4. Strategy Mapping
      • 7.3.4.1. Expansion
      • 7.3.4.2. Acquisition
      • 7.3.4.3. Collaborations
      • 7.3.4.4. Disease Type/Drug Class Launch
      • 7.3.4.5. Partnerships
      • 7.3.4.6. Others

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 3 Global Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 4 Global Central Lab Market, by Region, 2018 - 2030 (USD Million)
  • Table 5 North America Central Lab Market, by Country, 2018 - 2030 (USD Million)
  • Table 6 North America Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 7 North America Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 9 U.S. Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 10 Canada Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 11 Canada Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 12 Europe Central Lab Market, by Country, 2018 - 2030 (USD Million)
  • Table 13 Europe Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 14 Europe Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 15 Germany Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 16 Germany Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 UK Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 18 UK Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 19 France Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 20 France Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 21 Italy Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 22 Italy Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 23 Spain Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 24 Spain Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Denmark Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 26 Denmark Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 27 Sweden Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 28 Sweden Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 29 Norway Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 30 Norway Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific Central Lab Market, by Country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 34 China Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 35 China Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Japan Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 37 Japan Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 38 India Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 39 India Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 40 South Korea Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 41 South Korea Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Australia Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 43 Australia Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 44 Thailand Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 45 Thailand Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 46 Latin America Central Lab Market, by Country, 2018 - 2030 (USD Million)
  • Table 47 Latin America Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 48 Latin America Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 49 Brazil Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 50 Brazil Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 51 Mexico Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 52 Mexico Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 53 Argentina Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 54 Argentina Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 58 South Africa Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 59 South Africa Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 62 UAE Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 63 UAE Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 64 Kuwait Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 65 Kuwait Central Lab Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Central Lab Market Segmentation
  • Fig. 8 Market Snapshot, 2023
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 PESTEL Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Global Central Lab Market: Service Movement Analysis
  • Fig. 15 Global Central Lab Market, by Genetic Services, 2018 - 2030 (USD Million)
  • Fig. 16 Global Central Lab Market, by Biomarker Services, 2018 - 2030 (USD Million)
  • Fig. 17 Global Central Lab Market, by Anatomic Pathology/Histology, 2018 - 2030 (USD Million)
  • Fig. 18 Global Central Lab Market, by Specimen Management & Storage, 2018 - 2030 (USD Million)
  • Fig. 19 Global Central Lab Market, by Special Chemistry Services, 2018 - 2030 (USD Million)
  • Fig. 20 Global Central Lab Market, by Others, 2018 - 2030 (USD Million)
  • Fig. 21 Global Central Lab Market: End-Use Movement Analysis
  • Fig. 22 Global Central Lab Market, by Pharmaceutical Companies 2018 - 2030 (USD Million)
  • Fig. 23 Global Central Lab Market, by Biotechnology Companies 2018 - 2030 (USD Million)
  • Fig. 24 Global Central Lab Market, by Academic & Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 25 Regional Marketplace: Key Takeaways
  • Fig. 26 Regional Outlook, 2023 & 2030
  • Fig. 27 Global Central Lab Market: Region Movement Analysis
  • Fig. 28 North America Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 30 Canada Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 31 Europe Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 32 Germany Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 33 UK Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 34 France Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 35 Italy Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 36 Spain Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 37 Denmark Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 38 Sweden Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 39 Norway Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 40 Asia Pacific Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 41 Japan Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 42 China Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 43 India Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 44 Australia Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 45 South Korea Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 46 Thailand Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 47 Latin America Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 48 Brazil Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 52 South Africa Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 54 UAE Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait Central Lab Market, 2018 - 2030 (USD Million)